- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 125.08M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 129.37K sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 126.04K sh |
| Capex | Q1 2026 · Mar 31, 2026 | $0 |
| Capex | Q1 2026 · Mar 31, 2025 | $608K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $2.24M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$30.38M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $101.47M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $107.96M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $7.95M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $1M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $34.76M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $42.91M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $189.65M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $189.48M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $142.66M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $157.54M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $163.2M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $129.84M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $270.36M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $243.49M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $438.06M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $411.23M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $460M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $432.97M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.09 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.20 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.09 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.20 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $74.08M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $64M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $30.63M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $17.54M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$11.3M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$25.06M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$9.09M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$24.53M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $9.78M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $8.83M |
| Revenue | Q1 2026 · Mar 31, 2026 | $105.4M |
| Revenue | Q1 2026 · Mar 31, 2025 | $65.85M |